Loading clinical trials...
Loading clinical trials...
A Multiple-Dose, Non-Randomized, Open-Label, Multicenter Study to Evaluate the Long-Term Safety and Effectiveness of EN3267 in the Treatment of Breakthrough Pain in Cancer Patients
Conditions
Interventions
EN3267
Locations
1
United States
Carolinas Pain Institute
Winston-Salem, North Carolina, United States
Start Date
December 1, 2005
Primary Completion Date
December 1, 2008
Completion Date
January 1, 2009
Last Updated
June 18, 2024
NCT04550494
NCT05372640
NCT04235764
NCT03375307
NCT04929028
NCT05673200
Lead Sponsor
Kyowa Kirin Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions